MFS
ARRY

MSI Financial Services’s Array Biopharma Inc ARRY Stock Holding History

MSI Financial Services’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$18K Buy
+2,000
New +$14.7K ﹤0.01% 2476

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

MSI Financial Services's ARRY Position: Q4 2016 in Review

MSI Financial Services opened a new position in Array Biopharma Inc (ARRY) in Q4 2016: 2,000 shares worth $18K. The stake represents ﹤0.01% of the portfolio and ranks #2476 among its holdings.

167 funds tracked by Wall St. Rank hold ARRY as of Q4 2016.

  • MSI Financial Services held 2,000 shares of Array Biopharma Inc worth $18K as of Q4 2016.
  • Array Biopharma Inc was a new MSI Financial Services position in Q4 2016.
  • Array Biopharma Inc made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #2476 holding.
  • 167 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.